Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’ By: MarketWatch April 29, 2022 at 12:17 PM EDT The company says tirzepatide can help people lose up to 22.5% of their body weight. Read More >> Related Stocks: Eisai Ltd ADR Eli Lilly Pfizer
